Cetera Advisor Networks LLC Fulgent Genetics, Inc. Transaction History

Cetera Advisor Networks LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$49.85 - $96.11 $183,148 - $353,108	-3,674 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $116,877 - $158,760	-1,512 Reduced 29.16%	3,674 $370,000
Q3 2021 Nov 16, 2021	BUY	$74.87 - $110.87 $29,573 - $43,793	395 Added 8.24%	5,186 $466,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $320,038 - $481,255	4,791 New	4,791 $442,000
Q3 2020 Nov 13, 2020	SELL	$15.89 - $50.51 $1,589 - $5,051	-100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.89 - $18.28 $889 - $1,828	100 New	100 $2,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.